ᓇᐃᑦᑐᒥᒃ ᑭᐅᔾᔪᑎ
2024-mi Lancet Commission-ᑯᑦ ᐅᖃᐅᓯᖏᑦ 14 ᐋᖅᑭᒋᐊᕈᓐᓇᖅᑐᑦ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᑦ: ᐃᓕᓐᓂᐊᕐᓂᖅ ᐊᒥᓲᙱᓐᓂᖅ, ᑐᓵᓱᓐᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᖅ, LDL ᐅᖅᓱᖅ ᖁᑦᓯᖕᓂᖅ ᐊᐅᒃᑯᑦ, ᐃᓱᒪᒋᔭᐅᙱᓐᓂᖅ, ᓂᐱᐊᒃᑯᑦ ᐋᓐᓂᐊᖃᕐᓂᖅ, ᐊᐅᓚᓂᖅ ᐊᒥᓲᙱᓐᓂᖅ, ᓯᓚᒃᑯᑦ ᐊᐅᒃᓯᒪᓂᖅ, ᐳᔭᖅᑐᓂᖅ, ᐊᐅᒃ ᐱᔪᒃᓴᐅᓂᖅ ᖁᑦᓯᖕᓂᖅ, ᐅᖁᒪᐃᓪᓕᕐᓂᖅ, ᐃᒥᐊᓗᒃᑕᐅᓂᖅ ᐊᒥᓲᓂᖅ, ᐃᓄᒻᒧᑦ ᐊᕕᑦᑐᖅᓯᒪᙱᓐᓂᖅ, ᓯᓚᒧᑦ ᓯᓚᒐᖃᙱᓐᓂᖅ ᐊᒻᒪ ᐃᔨᓂᒃ ᐋᓐᓂᐊᖃᕐᓂᖅ ᐱᔨᑦᑎᕋᖅᑕᐅᙱᑦᑐᖅ. ᑕᒪᕐᒥᑦᑎᒍᑦ ᐊᑕᖏᖅᑐᑦ ᐱᔾᔪᑕᐅᔪᑦ ᐃᒪᓐᓇ 45%-ᒥᒃ ᐊᔾᔨᒌᙱᑦᑐᓂᒃ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᓄᑦ ᓄᓇᕐᔪᐊᕐᒥ, ᑭᓯᐊᓂ ᐊᑐᐃᓐᓇᐅᔪᖅ ᐃᓄᒃ ᐊᑕᐅᓯᕐᒧᑦ ᓇᓗᓇᐃᖅᓯᔾᔪᑎᖃᙱᑦᑐᖅ.
- 14 ᐱᔾᔪᑕᐅᔪᑦ ᐃᓅᓯᕐᒥ ᑕᒪᐃᓐᓂ ᐊᑐᖅᑕᐅᔪᑦ: ᐊᑕᐅᓯᖅ ᒪᒃᑯᒃᑐᓂ, ᖁᓕᑦ ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ, ᐲᖓᑦ ᐃᓐᓇᐅᓂᕐᒧᑦ ᐃᓅᓯᕐᒥ.
- ᑐᓵᓱᓐᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᖅ ᐊᒻᒪ LDL ᐅᖅᓱᖅ ᖁᑦᓯᖕᓂᖅ ᐊᐅᒃᑯᑦ ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ ᐊᑕᐅᓯᖅ ᐃᒪᓐᓇ 7%-ᒥᒃ ᐊᔾᔨᒌᙱᑦᑐᓂᒃ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᓄᑦ ᓄᓇᕐᔪᐊᕐᒥ ᐊᑕᖏᖅᑐᑦ, ᐊᖏᓂᖅᓴᐅᓪᓗᑎᒃ ᐊᔾᔨᒌᙱᑦᑐᓂᒃ ᐱᔾᔪᑕᐅᔪᓂ.
- ᑖᒃᑯᐊ ᐊᒥᓱᓂᖏᑦ ᓈᓴᐅᑎᑦ ᐃᓄᖕᓄᑦ ᑲᑎᙵᔪᓄᑦ ᓇᓗᓇᐃᖅᓯᒪᔪᑦ, ᐱᔾᔪᑎᒋᓪᓗᒋᑦ ᐊᒻᒪ ᖃᓄᐃᓕᖓᓂᖏᑦ ᐃᓚᖏᑦ ᐃᓗᐃᓐᓇᕐᒥᒃ ᐱᔾᔪᑎᒋᔪᑦ ᐃᓱᒪᒋᔭᐅᔪᑦ.
- ᐅᑭᐅᖅᑕᖅᑐᖅ ᐊᒻᒪ ᑭᖑᓂᐊᒍᑦ ᐱᔾᔪᑕᐅᔪᑦ, ᑭᓇᐅᓂᕐᒧᑦ ᐋᖅᑭᒋᐊᕈᓐᓇᙱᑦᑐᑦ, ᐊᖏᔪᒻᒥᒃ ᐱᔾᔪᑕᐅᔪᑦ ᐅᕗᖓᑦᑎᐊᕆᐅᖅᑐᑦ. 14 ᐱᔾᔪᑕᐅᔪᑦ ᒥᑭᓪᓕᒋᐊᕐᓂᖏᑦ ᓇᓗᓇᐃᖅᓯᙱᑦᑐᑦ ᑭᓇᐅᓂᕐᒧᑦ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖅ ᐱᑕᖃᙱᓐᓂᖓᓂᒃ.
- ᐊᒥᓱᑦ ᐱᓕᕆᐊᑦ ᐃᓚᒋᔭᐅᔪᑦ, ᓲᕐᓗ ᐊᐅᒃ ᐱᔪᒃᓴᐅᓂᖓ, ᑐᓵᓱᓂᖓ ᐊᒻᒪ ᐃᔨᓂᒃ ᑕᑯᓂᖓ ᖃᐅᔨᓴᕐᓂᖅ, ᐋᓐᓂᐊᕈᑎᒧᑦ ᐱᐅᔪᑦ ᐊᓯᖏᓐᓄᑦ ᐊᒻᒪ ᐋᓐᓂᐊᖃᖅᑎᒧᑦ ᐅᖃᖃᑎᒋᔭᐅᔪᓐᓇᖅᑐᑦ.
ᑕᕝᕙᓂ ᒪᒃᐱᒐᕐᒥ (7 ᐃᓚᖏᑦ)
ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᖅ ᐅᖃᐅᓯᕙᒃᑐᖅ ᐊᔪᕈᓐᓃᕐᓂᖅ ᐊᖏᓂᖅᓴᒧᑦ ᐱᑕᖃᕈᓐᓇᕐᓂᖓᓂᒃ. ᑕᐃᒪᐃᑦᑐᐃᓐᓇᕆᐊᖃᙱᑦᑐᖅ ᐊᔾᔨᒌᙱᑦᑐᓂ, ᐱᔾᔪᑕᐅᔪᖃᕐᓂᖅ ᑐᑭᓯᙱᑦᑐᖅ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖃᕐᓂᐊᖅᑐᑎᑦ. ᐅᕙᓂ ᒪᒃᐱᖅᑐᒐᕐᒥ ᑎᑎᕋᖅᓯᒪᔪᑦ 14 ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᑦ 2024-mi Lancet Commission-ᑯᑦ ᐅᖃᐅᓯᒪᔭᖏᑦ ᐋᖅᑭᒋᐊᕈᓐᓇᖅᑐᑦ, ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᖃᓄᐃᓕᖓᓂᖏᑦ, ᐊᒻᒪ ᐋᓐᓂᐊᖃᖅᑎᒧᑦ ᐅᖃᖃᑎᒋᔭᐅᔪᓐᓇᖅᑐᑦ.
ᐱᓕᕆᔾᔪᓯᕐᒥᒃ ᑕᒪᕐᒥᓂᒃ ᑐᑭᓯᔪᒪᒍᕕᑦ, ᐊᖏᔪᓂᒃ ᐆᑦᑐᕋᐅᑎᓂᒃ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᓂᒃ ᐱᖃᓯᐅᑎᓪᓗᒍ, ᐱᒋᐊᕐᓗᑎᑦ ᐅᕙᓂ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖅ ᓴᐳᒻᒥᔭᐅᔪᓐᓇᖅᐸ? ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᐅᖃᐅᓯᖏᑦ. ᑖᓐᓇ ᑐᑭᓯᐅᒪᔾᔪᑎᒥᒃ ᑐᓴᐅᒪᔾᔪᑎᐅᔪᖅ, ᐋᓐᓂᐊᖃᖅᑎᒧᑦ ᐊᑐᖅᑕᐅᔪᓐᓇᙱᑦᑐᖅ; ᑕᑯᓗᒍ ᐋᓐᓂᐊᖃᖅᑎᒧᑦ ᓇᓗᓇᐃᔭᖅᓯᒪᓂᖅ.
ᑭᓲᑦ 14 ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᑦ?
2024-mi Lancet Commission, 27 ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᖃᐅᔨᓴᖅᑎᓄᑦ ᑎᑎᕋᖅᓯᒪᔪᖅ, ᓇᓗᓇᐃᖅᓯᒪᒻᒪᑦ 14 ᐋᖅᑭᒋᐊᕈᓐᓇᖅᑐᑦ ᐱᔾᔪᑕᐅᔪᑦ ᑲᑎᙵᔪᑦ ᐃᒪᓐᓇ 45%-ᒥᒃ ᐊᔾᔨᒌᙱᑦᑐᓂᒃ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᓄᑦ ᓄᓇᕐᔪᐊᕐᒥ ᐊᑕᖏᖅᑐᑦ. ᐊᒥᓱᓂᖅ ᐊᑕᐅᓯᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᒧᑦ ᐊᑦᑕᕐᓇᖅᑐᒦᑦᑐᖅ Commission-ᑯᑦ ᓇᓗᓇᐃᖅᓯᒪᓂᖓ ᐊᔾᔨᒌᙱᑦᑐᓂᒃ ᓄᓇᕐᔪᐊᕐᒥ ᐊᑕᖏᖅᓯᒪᔪᖅ, ᓈᓴᐅᑎᓄᑦ ᐊᒥᓲᓄᑦ ᒥᓯᖅᑕᐅᓯᒪᔪᖅ. ᓈᓴᐅᑏᑦ ᐃᓚᒃᑲᑕᖃᖅᑐᑦ, ᐃᓄᑦᑎᑑᖅᑐᑦ ᐊᒥᓱᓂᒃ ᐱᔾᔪᑕᐅᔪᖃᖃᑦᑕᕐᒪᑕ, ᑖᓐᓇ ᐱᔾᔪᑎᒋᓪᓗᒍ 45%-ᒧᑦ ᑲᑎᑦᑎᔪᑦ ᐊᒥᓲᓂᕐᒧᑦ ᐱᖓᓱᓐᓂᖅᓴᒥᓂᒃ.
| ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᖅ | ᐃᓅᓯᕐᒧᑦ ᐊᑐᖅᑕᐅᓂᖅ | ᐊᔾᔨᒌᙱᑦᑐᑦ | ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᖃᓄᐃᓕᖓᓂᖏᑦ | ᖃᓄᐃᓕᐅᕈᓐᓇᖅᑐᑎᑦ |
|---|---|---|---|---|
| ᐃᓕᓐᓂᐊᕐᓂᖅ ᐊᒥᓲᙱᓐᓂᖅ | ᒪᒃᑯᒃᑐᓂ ᐃᓅᓯᕐᒥ | 5% | ᐃᓕᓐᓂᐊᕐᕕᒻᒥ ᐅᑭᐅᑦ ᐊᒥᓲᙱᓐᓂᖏᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᑦ. ᐃᓱᒪᒥᒃ ᐱᓕᕆᓂᖅ ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ ᓴᐳᑦᑎᔪᓐᓇᖅᑐᖅ, ᐃᓕᓐᓂᐊᕐᓂᖅ ᐊᒥᓲᙱᓚᐅᖅᑐᓄᑦ ᐊᒻᒪᓗ. | ᐃᓕᑦᑎᐊᕆᑦᑕᐃᓕᒪᓂᖅ ᐊᒻᒪ ᐃᓱᒪᒥᒃ ᐱᓕᕆᓂᖃᕐᓂᖅ ᐅᑭᐅᖅᑕᖅᑐᓂ ᑕᒪᐃᓐᓂ: ᐅᖃᓕᒫᕐᓂᖅ, ᐱᔪᒪᔭᑎᑦ, ᐃᓕᓐᓂᐊᕈᑎᑦ, ᐱᙳᐊᖅᑐᑦ ᐊᓯᖏᓐᓂ. |
| ᑐᓵᓱᓐᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᖅ | ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ | 7% | ᑐᓵᓱᓐᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᖅ ᐱᔨᑦᑎᕋᖅᑕᐅᙱᑦᑐᖅ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. ᐃᓄᐃᑦ ᐅᑭᐅᑦ ᐊᒥᓱᑦ ᒪᓕᒃᖢᒋᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᑐᓵᓱᓂᕐᒧᑦ ᐃᑲᔪᖅᑐᐃᑦ ᐊᑐᖅᑕᐅᓂᖏᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᒥᑭᓪᓕᖅᓴᐅᓂᖏᓐᓂᒃ ᐊᑕᖏᖅᑐᑦ. | ᑐᓵᓱᓂᕆᔭᑎᑦ ᖃᐅᔨᓴᖅᑕᐅᓗᑎᑦ. ᑐᓵᓱᓂᕐᒧᑦ ᐃᑲᔪᖅᑐᐃᑦ ᐃᑲᔪᖅᑐᐃᔪᓐᓇᖅᒪᖔᑕ ᐊᐱᕆᓗᑎᑦ, ᐊᑐᕐᓗᒋᑦ ᐊᑐᖅᑕᐅᒃᑲᓐᓂᕈᕕᑦ. ᓯᐅᑎᑦ ᓴᐳᑦᑎᓗᒋᑦ ᓂᐱᓪᓗᐊᖅᑐᓂᒃ. |
| LDL ᐅᖅᓱᖅ ᖁᑦᓯᖕᓂᖅ ᐊᐅᒃᑯᑦ | ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ (ᐃᒪᓐᓇ 40-ᓂᒃ) | 7% | LDL ᐅᖅᓱᖅ ᖁᑦᓯᖕᓂᖅ ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᐃᓄᐃᑦ ᒪᓕᒃᖢᒋᑦ ᑕᑯᔭᖅᑐᐃᓪᓗᑎᒃ statin-ᓂᒃ ᐊᑐᖅᑐᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᒥᑭᓪᓕᖅᓴᐅᓂᖏᓐᓂᒃ ᐊᑕᖏᖅᑐᑦ, ᑭᓯᐊᓂ ᐆᑦᑐᕋᐅᑏᑦ ᐃᓐᓇᐅᓂᕐᒧᑦ ᐃᓅᓯᕐᒥ ᑕᒪᓐᓇ ᑕᑯᒃᓴᐅᙱᑦᑐᑦ. | ᐋᓐᓂᐊᖃᖅᑎᒧᑦ ᐊᐱᕆᓗᑎᑦ ᐅᖅᓱᐊᓗᒃᑕᖅ ᖃᐅᔨᓴᖅᑕᐅᔭᕆᐊᖃᖅᐸᑦ ᐊᒻᒪ ᖃᓄᐃᓕᐅᕈᓐᓇᖅᑐᑎᑦ. |
| ᐃᓱᒪᒋᔭᐅᙱᓐᓂᖅ | ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ | 3% | ᐃᓱᒪᒋᔭᐅᙱᓐᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. ᐃᓐᓇᐅᓂᕐᒧᑦ ᐃᓅᓯᕐᒥ, ᐃᓱᒪᒋᔭᐅᙱᓐᓂᖅ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᓇᓗᓇᐃᒃᑯᑕᐅᔪᓐᓇᖅᑐᖅ. | ᐋᓐᓂᐊᖃᖅᑎᒧᑦ ᐅᖃᐅᑎᓗᑎᑦ ᐃᓱᒪᒋᔭᐅᙱᓐᓂᕐᒧᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐱᔪᒪᔭᐅᔪᓂᒃ ᐱᖁᔭᐅᓂᕐᒧᑦ ᒪᕐᕉᒃ ᐱᓇᓱᐊᕈᓯᕐᒧᑦ ᐅᖓᑖᓂᒃ ᐱᔭᕇᖅᓯᒪᒃᑲᓐᓂᕐᐸᑦ. ᐃᓱᒪᒋᔭᐅᙱᓐᓂᖅ ᐋᓐᓂᐊᖅᑕᐅᔪᓐᓇᖅᑐᖅ. |
| ᓂᐱᐊᒃᑯᑦ ᐋᓐᓂᐊᖃᕐᓂᖅ | ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ | 3% | ᓂᐱᐊᒃᑯᑦ ᐋᓐᓂᐊᖃᕐᓂᖅ ᐅᑭᐅᖅᑕᖅᑐᓂ ᑕᒪᐃᓐᓂ ᐊᒻᒪ ᓇᓄᑐᐃᓐᓇᖅ ᐱᔾᔪᑎᖃᕐᓂᖓᓂ, ᐱᙳᐊᖅᑎᓄᑦ ᐱᙳᐊᖃᑦᑕᕐᓂᕐᒧᑦ ᐃᓚᒋᓗᒍ, ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. | ᓂᐱᐊᒃᑯᑦ ᓴᐳᑎᓯᒪᓂᖃᕐᓗᑎᑦ ᓯᕙᓯᔭᐅᑎᒥᒃ ᐃᖏᕐᕋᐅᑎᕐᓂ ᐊᒻᒪ ᐱᙳᐊᖃᑦᑕᕐᓂᕐᒥ. ᐊᐱᕆᓗᑎᑦ ᖃᓄᖅ ᐊᑲᐅᙱᓕᐅᕈᓐᓇᖅᑐᑎᑦ ᓴᐳᑎᓯᒪᓂᕐᒧᑦ. ᓂᐱᐊᒃᑯᑦ ᐋᓐᓂᐊᖃᖅᑎᓪᓗᒍ ᒪᓂᖅᓯᐅᕐᓗᑎᑦ ᐊᒻᒪ ᖃᐅᔨᓴᖅᑕᐅᓗᑎᑦ. |
| ᐊᐅᓚᓂᖅ ᐊᒥᓲᙱᓐᓂᖅ | ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ | 2% | ᐊᐅᓚᖃᑦᑕᖅᑐᑦ ᐱᙳᐊᖃᑦᑕᖅᑐᓪᓗ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖃᕐᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᖅᓴᐅᔪᑦ. ᐆᑦᑐᕋᐅᑏᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᓱᓕ ᐊᒥᓲᙱᑦᑐᑦ. | ᐋᓐᓂᐊᖃᖅᑎᒧᑦ ᐊᐱᕆᓗᑎᑦ ᖃᓄᖅ ᐊᐅᓚᓂᖅ ᐊᑦᑕᕐᓇᖅᑐᖅ ᐃᓕᖕᓄᑦ. ᐱᔪᒪᔭᑎᑦ ᓇᓂᓗᑎᑦ. ᑕᑯᓗᒍ ᐊᐅᓚᓂᕐᒧᑦ ᒪᓕᒐᖅ. |
| ᓯᓚᒃᑯᑦ ᐊᐅᒃᓯᒪᓂᖅ | ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ | 2% | ᓯᓚᒃᑯᑦ ᐊᐅᒃᓯᒪᓂᖅ, ᐱᓗᐊᖅᑐᒥᒃ ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ ᐱᒋᐊᖅᑎᓪᓗᒍ ᐅᕝᕙᓘᓐᓃᑦ ᐅᖓᑖᓂᒃ ᐱᔭᕇᖅᓯᒪᒃᑲᓐᓂᕐᐸᑦ, ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. | ᐊᐅᒃ ᓯᓚᒃᑯᑦ ᖃᐅᔨᓴᖅᑕᐅᓗᑎᑦ. ᓯᓚᒃᑯᑦ ᐊᐅᒃᓯᒪᓂᖃᖅᑎᓪᓗᒍ, ᐋᓐᓂᐊᖃᖅᑐᓂᒃ ᐱᓕᕆᖃᑎᒋᓗᒋᑦ ᐊᑦᑕᕐᓇᖅᑐᒦᑦᑎᓗᑎᑦ. |
| ᐳᔭᖅᑐᓂᖅ | ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ | 2% | ᐳᔭᖅᑐᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᑕᑯᒃᓴᐅᑎᑦᑎᔪᑦ ᐳᔭᕐᓂᕐᒥᒃ ᓄᖅᑲᖅᑎᓪᓗᑎᒃ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᔾᔨᖓᓂᖃᙱᓐᓂᖏᓐᓂᒃ ᐱᔭᕇᖅᓯᒪᔪᓄᑦ. | ᐃᑲᔪᖅᑐᐃᓂᕐᒧᑦ ᐊᐱᕆᓗᑎᑦ ᓄᖅᑲᕐᓂᕐᒧᑦ. ᐅᑭᐅᖅᑕᖅᑐᓂ ᑕᒪᐃᓐᓂ ᓄᖅᑲᕐᓂᖅ ᐱᐅᔪᖅ. |
| ᐊᐅᒃ ᐱᔪᒃᓴᐅᓂᖅ ᖁᑦᓯᖕᓂᖅ | ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ | 2% | ᐊᐅᒃ ᐱᔪᒃᓴᐅᓂᖅ ᖁᑦᓯᖕᓂᖅ ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. ᐊᐅᒃ ᐱᔪᒃᓴᐅᓂᕐᒧᑦ ᐋᓐᓂᐊᖅᑕᐅᑏᑦ ᐆᑦᑐᕋᐅᑎᖏᑦ ᑕᑯᒃᓴᐅᑎᑦᑎᔪᑦ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐃᓱᒪᒃᓴᖅᓯᐅᕈᓐᓇᕐᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᒥᑭᓪᓕᖅᓴᐅᓂᖏᓐᓂᒃ. | ᓈᓴᐅᑎᑎᑦ ᖃᐅᔨᒋᐊᕐᓗᒋᑦ. Commission-ᑯᑦ ᐅᖃᐅᓯᕙᒃᑐᑦ ᖁᓛᓂ ᓈᓴᐅᑎ 130-ᒧᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐊᑖᓂᒃ ᐃᒪᓐᓇ 40 ᐅᑭᐅᓂᒃ ᐱᒋᐊᕐᓗᒍ; ᐊᐱᕆᓗᑎᑦ ᖃᓄᖅ ᐱᐅᔪᖅ ᐃᓕᖕᓄᑦ. |
| ᐅᖁᒪᐃᓪᓕᕐᓂᖅ | ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ | 1% | ᐅᖁᒪᐃᓪᓕᕐᓂᖅ ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ, ᓯᓚᒃᑯᑦ ᐊᐅᒃᓯᒪᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᒻᒪᓗ. | ᐋᓐᓂᐊᖃᖅᑎᒧᑦ ᐊᐱᕆᓗᑎᑦ ᐋᓐᓂᐊᕈᑎᒧᑦ ᐱᐅᔪᖅ ᐅᖁᒪᐃᓪᓕᕐᓂᖅ ᐃᓕᖕᓄᑦ. ᐃᓐᓇᐅᓂᕐᒧᑦ ᐃᓅᓯᕐᒥ ᐃᓐᓇᐃᑦ ᓂᕆᔭᒃᓴᖏᓐᓂᒃ ᒥᑭᓪᓕᒋᐊᕆᐊᖃᙱᑦᑐᑦ ᐋᓐᓂᐊᖃᖅᑎ ᐅᖃᖃᑎᒋᙱᓪᓗᒍ. |
| ᐃᒥᐊᓗᒃᑕᐅᓂᖅ ᐊᒥᓲᓂᖅ | ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ | 1% | ᐃᒥᐊᓗᒃᑕᐅᓂᖅ ᐊᒥᓲᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. ᐊᒥᓲᓂᖅ ᒥᑭᓪᓕᒋᐊᕐᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᒥᑭᓪᓕᖅᓴᐅᓂᖏᓐᓂᒃ ᐊᑕᖏᖅᑐᖅ. | ᐊᐱᕆᓗᑎᑦ ᖃᓄᖅ ᐊᑦᑕᕐᓇᖅᑐᖅ ᐃᓕᖕᓄᑦ, ᐱᓗᐊᖅᑐᒥᒃ ᐋᓐᓂᐊᖅᑕᐅᑎᑎᑦ ᐊᑐᖅᑕᐅᒃᑲᓐᓂᕐᒪᑕ. |
| ᐃᓄᒻᒧᑦ ᐊᕕᑦᑐᖅᓯᒪᙱᓐᓂᖅ | ᐃᓐᓇᐅᓂᕐᒧᑦ ᐃᓅᓯᕐᒥ | 5% | ᐃᓄᓐᓂᒃ ᐊᕕᑦᑐᖅᓯᒪᙱᓐᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. | ᐃᓄᓐᓂᒃ ᐊᕕᑦᑐᖅᓯᒪᓂᖃᕐᓗᑎᑦ ᐱᔪᒪᔭᑎᑦ ᐊᑐᕐᓗᒋᑦ. ᑕᑯᓗᒍ ᐃᓄᒻᒧᑦ ᐊᕕᑦᑐᖅᓯᒪᓂᕐᒧᑦ ᒪᓕᒐᖅ. |
| ᓯᓚᒧᑦ ᓯᓚᒐᖃᙱᓐᓂᖅ | ᐃᓐᓇᐅᓂᕐᒧᑦ ᐃᓅᓯᕐᒥ | 3% | ᓯᓚ ᓯᓚᒐᖃᙱᑦᑐᒥ ᐃᓅᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᓯᓚ ᓴᓗᒪᔪᖅ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᒥᑭᓪᓕᖅᓴᐅᓂᖏᓐᓂᒃ ᐊᑕᖏᖅᑐᑦ. | ᑖᓐᓇ ᐊᒥᓱᓂᕐᒧᑦ ᒐᕙᒪᒃᑯᓐᓄᑦ ᐱᓕᕆᐊᖑᔪᖅ. ᓄᓇᓕᓐᓂ ᓯᓚᒧᑦ ᖃᓄᐃᓕᖓᓂᖓᓂᒃ ᓇᓗᓇᐃᔭᐃᑦ ᖃᐅᔨᒋᐊᕐᓗᒋᑦ ᐊᒻᒪ ᓯᓚᒐᖃᙱᑦᑐᓂ ᐅᓪᓗᓂ ᓯᓚᒥ ᐃᓅᓂᕐᒥᒃ ᒥᑭᓪᓕᒋᐊᕐᓗᑎᑦ. |
| ᐃᔨᓂᒃ ᐋᓐᓂᐊᖃᕐᓂᖅ ᐱᔨᑦᑎᕋᖅᑕᐅᙱᑦᑐᖅ | ᐃᓐᓇᐅᓂᕐᒧᑦ ᐃᓅᓯᕐᒥ | 2% | ᐃᔨᓂᒃ ᐋᓐᓂᐊᖃᕐᓂᖅ ᐋᖅᑭᒃᓯᒪᙱᑦᑐᖅ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᐊᑕᖏᖅᑐᖅ. ᐊᖏᔪᖅ ᐊᒥᐊᓕᒃ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᖅ ᐃᔨᓄᑦ ᐋᓐᓂᐊᖅᑕᐅᓂᖅ (cataract surgery) ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᒥᑭᓪᓕᖅᓴᐅᓂᖏᓐᓂᒃ ᐊᑕᖏᖅᑐᖅ. | ᐃᔨᑎᑦ ᖃᐅᔨᓴᖅᑕᐅᕙᕆᐊᖃᑦᑕᕐᓗᒋᑦ. ᐊᐱᕆᓗᑎᑦ ᐋᓐᓂᐊᖃᕐᓂᐅᔪᑦ, ᓲᕐᓗ ᐃᔨᓄᑦ ᖃᓂᖅᑐᐃᓐᓇᖅ, ᐋᓐᓂᐊᖅᑕᐅᔪᓐᓇᖅᒪᖔᑕ. |
ᖃᓄᖅ ᑖᒃᑯᐊ ᐊᒥᓱᓂᖏᑦ ᑐᑭᓯᔭᕆᐊᖃᖅᐸᒃᑲ?
ᐋᑯᓐᓂᖅᓱᖅᑕᐅᓗᑎᑦ. Commission-ᑯᑦ ᐅᓂᒃᑳᖓ ᓇᓗᓇᐃᖅᓯᕙᒃᑐᖅ ᐃᓱᒪᒋᐊᖃᖅᑐᓂᒃ ᐃᖅᑲᐅᒪᔭᐅᔪᓂᒃ:
- ᐃᓄᖕᓄᑦ ᑲᑎᙵᔪᓄᑦ ᐅᖃᐅᓯᕙᒃᑐᑦ, ᐃᓄᒃ ᐊᑕᐅᓯᕐᒧᑦ ᐱᔾᔪᑎᙱᑦᑐᑦ. University College London-ᑯᑦ ᐅᓂᒃᑳᕐᒧᑦ ᓇᐃᓈᖅᓯᒪᔪᖅ ᐅᖃᐅᓯᕙᒃᑐᖅ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᑦ ᒥᑭᓪᓕᒋᐊᕐᓂᖏᑦ ᐃᓄᖕᓄᑦ ᑲᑎᙵᔪᓄᑦ ᐃᑲᔪᖅᑐᐃᔪᑦ, ᑭᓯᐊᓂ ᐃᓄᒃ ᐊᑕᐅᓯᖅ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖃᙱᓐᓂᖓᓂᒃ ᓇᓗᓇᐃᖅᓯᙱᑦᑐᑦ.
- ᐱᔾᔪᑎᒋᓪᓗᒋᑦ ᖃᓄᐃᓕᖓᓂᖏᑦ ᐃᓱᒪᒋᔭᐅᔪᑦ. ᑎᑎᕋᖅᑎᑦ ᐱᔾᔪᑕᐅᔪᑦ ᐱᔾᔪᑎᒋᔪᓂᒃ ᓇᓗᓇᐃᖅᓯᒪᔪᓂᒃ ᐃᓚᓯᓚᐅᖅᑐᑦ, ᑭᓯᐊᓂ ᐅᖃᐅᓯᕙᒃᑐᑦ ᐃᓚᖏᑦ ᐃᓗᐃᓐᓇᕐᒥᒃ ᐱᔾᔪᑎᒋᔪᑦ ᐃᓱᒪᒋᔭᐅᔪᓐᓇᖅᑐᑦ.
- ᓄᓇᕐᔪᐊᕐᒥ ᑲᑎᙵᔪᓄᑦ ᓈᓴᐅᑏᑦ. ᐊᒥᓱᑦ ᑐᑭᓯᐅᒪᔾᔪᑎᑦ ᐊᑐᖅᑕᐅᓯᒪᔪᑦ ᐊᑭᓕᕐᓂᖅᓴᓂᒃ ᓄᓇᓕᓐᓂ, ᓄᓇᓕᒻᒥ ᐅᕝᕙᓘᓐᓃᑦ ᓄᓇᓕᒻᒥ ᐊᔾᔨᒌᙱᑦᑐᑦ ᐊᔾᔨᒋᔪᓐᓇᖅᑐᑦ.
- ᒥᑭᑦᑐᑦ ᐊᒥᓱᓂᖏᑦ ᐱᒻᒪᕆᐅᔪᓐᓇᖅᑐᑦ. ᐱᔾᔪᑕᐅᔪᖅ 2%-ᒥᒃ ᐊᔾᔨᒌᙱᑦᑐᓂᒃ ᐊᑕᖏᖅᑐᖅ ᓄᓇᕐᔪᐊᕐᒥ ᐊᒥᓱᓂᒃ ᐃᓄᓐᓂᒃ ᐊᒃᑐᐃᓂᖃᕐᓂᐊᖅᑐᖅ.
ᓇᓕᐊᑦ ᐱᔾᔪᑕᐅᔪᑦ 2024-mi ᐃᓚᓯᐅᔪᑦ?
2024-mi ᐅᓂᒃᑳᖅ ᒪᕐᕉᒃ ᐱᔾᔪᑕᐅᔪᒃ ᐃᓚᓯᓚᐅᖅᑐᖅ 12-ᓄᑦ ᐅᖃᐅᓯᔭᐅᓚᐅᖅᑐᓄᑦ 2020-mi:
- LDL ᐅᖅᓱᖅ ᖁᑦᓯᖕᓂᖅ ᐊᐅᒃᑯᑦ ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ, ᐃᒪᓐᓇ 7%-ᒥᒃ ᐊᔾᔨᒌᙱᑦᑐᓂᒃ ᐊᑕᖏᖅᑐᖅ.
- ᐃᔨᓂᒃ ᐋᓐᓂᐊᖃᕐᓂᖅ ᐱᔨᑦᑎᕋᖅᑕᐅᙱᑦᑐᖅ ᐃᓐᓇᐅᓂᕐᒧᑦ ᐃᓅᓯᕐᒥ, ᐃᒪᓐᓇ 2%-ᒥᒃ ᐊᔾᔨᒌᙱᑦᑐᓂᒃ ᐊᑕᖏᖅᑐᖅ.
ᓇᓕᐊᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᑦ ᐋᖅᑭᒋᐊᕈᓐᓇᙱᑦᑐᑦ?
National Institute on Aging ᐅᖃᐅᓯᕙᒃᑐᖅ ᐅᑭᐅᖅᑕᖅᑐᖅ ᖃᐅᔨᒪᔭᐅᔪᓂᒃ ᐊᖏᓂᖅᓴᐅᔪᖅ ᐱᔾᔪᑕᐅᔪᖅ Alzheimer-ᒧᑦ, ᑭᓇᐅᓂᕐᒧᑦ ᐋᖅᑭᒋᐊᕈᓐᓇᙱᑦᑐᖅ. ᑭᖑᓂᐊᒍᑦ ᐱᔾᔪᑕᐅᔪᑦ ᐃᓚᒋᔭᐅᕗᑦ; ᖃᐅᔨᒪᔭᐅᔪᖅ ᑭᖑᓂᐊᒍᑦ ᐱᔾᔪᑕᐅᔪᖅ Alzheimer ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᖓᓄᑦ ᐊᒃᑐᐃᓂᖃᖅᑐᖅ APOE-ᒥᒃ ᐊᑎᖅᑕᐅᔪᖅ. NIA ᐅᖃᐅᓯᕙᒃᑐᖅ ᖃᐅᔨᓴᖅᑎᑦ ᓱᓕ ᓇᓗᓇᐃᖅᓯᒪᙱᑦᑐᑦ ᖃᓄᐃᑦᑐᑐᐃᓐᓇᕆᐊᖃᖅᑐᖓᑕ Alzheimer ᐊᒥᓱᓂᒃ ᐃᓄᓐᓂᒃ. Lancet Commission-ᑯᑦ ᐅᖃᐅᓯᕙᒃᑐᖅ ᐋᖅᑭᒋᐊᕈᓐᓇᖅᑐᑦ ᐱᔾᔪᑕᐅᔪᑦ ᒥᑭᓪᓕᒋᐊᕈᓐᓇᖅᑐᑦ ᑭᖑᓂᐊᒍᑦ ᐱᔾᔪᑕᐅᔪᖃᕐᓂᖓᓂ ᓇᓗᓇᐃᖅᓯᙱᑦᑐᑦ.
ᐅᑭᐅᖅᑕᖅᑐᖅ ᐊᒻᒪ ᑭᖑᓂᐊᒍᑦ ᐱᔾᔪᑕᐅᔪᑦ ᐊᖏᔪᒻᒥᒃ ᐱᔾᔪᑎᒋᔪᒪᑦ, ᐊᒥᓱᑦ ᐃᓄᑦ 14 ᐱᔾᔪᑕᐅᔪᖃᙱᑦᑐᑦ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖃᕐᓂᐊᖅᑐᑦ. ᑖᓐᓇ ᑭᓇᐅᓂᕐᒧᑦ ᐸᓯᔭᐅᙱᑦᑐᖅ.
ᖃᓄᖅ ᐆᑦᑐᕋᐅᑏᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᐅᖃᐅᓯᕙᖃᑦᑕᖅᐸᑦ ᑖᒃᑯᓄᖕᓂᒃ ᐱᔾᔪᑕᐅᔪᓂᒃ ᐋᖅᑭᒋᐊᕐᓂᕐᒧᑦ?
ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᖅ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᑕᖏᖅᓯᒪᓂᖓ ᐊᔾᔨᒋᙱᑦᑐᖅ ᐋᖅᑭᒋᐊᕐᓂᖓ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖅ ᒥᑭᓪᓕᒋᐊᕐᓂᖓᓂᒃ ᓇᓗᓇᐃᖅᓯᓂᕐᒥᒃ. ᐃᓚᖏᑦ ᐆᑦᑐᕋᐅᑏᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᖃᓄᐃᓕᖓᓂᖏᑦ ᐅᕙᓂ ᐅᖃᐅᓯᕙᒃᑐᑦ:
- ᐊᐅᒃ ᐱᔪᒃᓴᐅᓂᖅ. SPRINT MIND ᐆᑦᑐᕋᐅᑎᒥ, ᐊᐅᒃ ᐱᔪᒃᓴᐅᓂᕐᒧᑦ ᑲᔪᓰᓐᓇᕐᓂᖅ ᐊᑖᓂᖅᓴᒧᑦ ᐃᓱᒪᒃᓴᖅᓯᐅᕈᓐᓇᕐᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖅ ᒥᑭᓪᓕᖅᓴᐅᓚᐅᖅᑐᖅ. ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖅ ᒥᑭᓪᓕᖅᓴᐅᓂᖓ ᓇᓗᓇᐃᖅᓯᒪᙱᑦᑐᖅ, ᐆᑦᑐᕋᐅᑎ ᒥᑭᓂᖅᓴᐅᔪᓐᓇᖅᑐᖅ ᑕᒪᓐᓇ ᑕᑯᒃᓴᐅᑎᑦᑎᔪᓐᓇᕐᓂᖓᓄᑦ (SPRINT MIND JAMA-mi).
- ᑐᓵᓱᓂᕐᒧᑦ ᐃᑲᔪᖅᑐᐃᑦ. Lancet Commission-ᑯᑦ ᐅᖃᐅᓯᕙᒃᑐᖅ ᐱᖓᓱᓂᒃ ᐅᑭᐅᓂᒃ ᐆᑦᑐᕋᐅᑎᒥᒃ ᑐᓵᓱᓂᕐᒧᑦ ᐃᑲᔪᖅᑐᐃᓂᒃ ᐊᑐᖅᑐᓂᒃ ᐃᓱᒪᒃᓴᖅᓯᐅᕈᓐᓇᕐᓂᕐᒧᑦ ᐊᑐᐃᓐᓇᐅᓂᖃᙱᓚᐅᖅᑐᖓᓂᒃ, ᑭᓯᐊᓂ ᐃᑲᔪᖅᑐᐃᓚᐅᖅᑐᖅ ᐃᓄᓐᓂᒃ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᐅᔪᓂᒃ. ᐃᓄᐃᑦ ᐅᑭᐅᑦ ᐊᒥᓱᑦ ᒪᓕᒃᖢᒋᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᐃᑲᔪᖅᑐᐃᓂᒃ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐊᖏᓂᖅᓴᒧᑦ ᒥᑭᓪᓕᖅᓴᐅᓂᖏᓐᓂᒃ ᐊᑕᖏᖅᑐᑦ. ᑐᓵᓱᓂᕐᒧᑦ ᒪᓕᒐᖅ ᐅᓂᒃᑳᖅᑐᐊᖅᑐᖅ.
- ᐊᐅᓚᓂᖅ. National Institute on Aging ᐅᖃᐅᓯᕙᒃᑐᖅ ᐆᑦᑐᕋᐅᑏᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᓇᓗᓇᐃᖅᓯᔪᓐᓇᙱᑦᑐᑦ ᐊᐅᓚᓂᖅ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᓴᐳᒻᒥᔪᓐᓇᖅᑐᖓᓂᒃ ᐅᕝᕙᓘᓐᓃᑦ ᓄᖅᑲᖅᑎᑦᑎᔪᓐᓇᖅᑐᖓᓂᒃ ᐃᓱᒪᒃᓴᖅᓯᐅᕈᓐᓇᕐᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐅᕝᕙᓘᓐᓃᑦ Alzheimer-ᒧᑦ, ᑭᓯᐊᓂ ᐃᓚᖏᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᐃᓱᒪᒋᔭᐅᔪᑦ ᐅᑭᐅᖅᑕᖅᑐᒧᑦ ᐊᑐᖅᑐᒧᑦ ᐃᓱᒪᒃᓴᖅᓯᐅᕈᓐᓇᕐᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐃᑲᔪᖅᑐᐃᔪᓐᓇᖅᑐᖓᓂᒃ (NIA Alzheimer ᓴᐳᒻᒥᔭᐅᓂᖓᓂᒃ).
ᐆᑦᑐᕋᐅᑏᑦ ᐅᖓᑖᓂᒃ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖅ ᐱᑕᖃᕐᓂᖓᓂᒃ ᐅᑕᖅᑭᔪᑦ ᐊᑭᑐᔪᑦ ᐊᒻᒪ ᐊᑭᑐᔪᑦ, ᑖᓐᓇ ᐱᔾᔪᑎᒋᓪᓗᒍ ᐊᒥᓱᓂᒃ ᐱᔾᔪᑕᐅᔪᓄᑦ ᐱᐅᔪᒻᒪᕆᐅᔪᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᐃᓄᐃᑦ ᐅᑭᐅᑦ ᐊᒥᓱᑦ ᒪᓕᒃᖢᒋᑦ ᖃᐅᔨᓴᖅᑕᐅᓂᐊᖅᑐᑦ. ᑖᒃᑯᐊ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᐱᐅᔪᑦ, ᑭᓯᐊᓂ ᐆᑦᑐᕋᐅᑎᓂᒃ ᓴᙱᓂᖅᓴᐅᔪᑦ.
ᓯᓂᖅ ᐊᒻᒪ ᓂᕆᔭᒃᓴᑦ ᖃᓄᖅ ᐃᑉᐱᒋᔭᐅᕙᒃᐸᑦ?
Commission-ᑯᑦ ᓯᓂᕐᓂᖅ ᐊᒻᒪ ᓂᕆᔭᒃᓴᑦ ᖃᐅᔨᓴᖅᓯᒪᒻᒪᑦ, ᑭᓯᐊᓂ ᑎᑎᕋᐅᓯᒪᔪᓄᑦ ᐃᓚᓯᓚᐅᙱᑦᑐᑦ, ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᓇᓗᓇᐃᖅᓯᔪᓐᓇᙱᓚᐅᖅᑐᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐊᔾᔨᒌᙱᓚᐅᖅᑐᑦ. ᒪᓕᒐᕗᑦ ᓯᓂᕐᓂᕐᒧᑦ ᐊᒻᒪ ᓂᕆᔭᒃᓴᓄᑦ ᐅᖃᐅᓯᕙᒃᑐᑦ ᖃᐅᔨᒪᔭᐅᔪᓂᒃ.
ᐋᓐᓂᐊᖃᖅᑎᒧᑦ ᐅᖃᖃᑎᒋᓗᑎᑦ
ᐊᕐᕌᒍᑕᒫᑦ ᐋᓐᓂᐊᕈᑎᒧᑦ ᖃᐅᔨᓴᕐᓂᖅ ᐱᐅᔪᖅ ᑖᒃᑯᓄᖕᓂᒃ ᐅᖃᐅᓯᕐᓂᐊᕐᓗᑎᑦ. ᑖᓐᓇ ᑎᑎᕋᐅᓯᒪᔪᖅ ᐊᒃᓱᕈᓐᓇᖅᑐᑦ ᐊᐱᕆᓗᑎᑦ:
- ᖃᓄᖅ ᐃᑉᐱᒋᔭᐅᕙᑦ ᐊᐅᒃ ᐱᔪᒃᓴᐅᓂᖓ, ᐊᐅᒃ ᓯᓚᒃᑯᑦ, ᐊᒻᒪ ᐅᖅᓱᐊᓗᒃᑕᖓ ᓈᓴᐅᑏᑦ, ᐃᓚᖏᑦ ᐋᓐᓂᐊᖅᑕᐅᔭᕆᐊᖃᖅᐸᑦ?
- ᑐᓵᓱᓂᕆᔭᒃᑲ ᐊᒻᒪ ᐃᔨᒃᑲ ᖃᐅᔨᓴᖅᑕᐅᔭᕆᐊᖃᖅᐸᑦ?
- ᐊᐅᓚᓂᖓ ᐊᑦᑕᕐᓇᖅᐸ ᐊᒻᒪ ᓈᒻᒪᑦᑎᐊᖅᐸ ᐅᕙᖓ?
- ᐋᓐᓂᐊᖅᑕᐅᑎᖏᑦ ᐃᓚᖏᑦ ᐃᖅᑲᐅᒪᔾᔪᑎᒧᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐃᓱᒪᒃᓴᖅᓯᐅᕈᓐᓇᕐᓂᕐᒧᑦ ᐊᒃᑐᐃᓂᖃᖅᐸᑦ?
ᐋᓐᓂᐊᖅᑕᐅᑏᑦ, ᓂᕆᔭᒃᓴᑦ, ᓂᕆᙱᓐᓂᖅ, ᐊᐅᓚᓂᖅ ᐅᕝᕙᓘᓐᓃᑦ ᐋᓐᓂᐊᖅᑕᐅᑎᒃᑯᑦ ᐃᑲᔪᖅᑐᐃᑦ ᐋᖅᑭᒋᐊᙱᓪᓗᒋᑦ, ᐋᓐᓂᐊᖃᖅᑎᒧᑦ ᐅᖃᖃᑎᒋᓗᑎᑦ ᓯᕗᓪᓕᖅᐹᒥ. ᐃᓕᒃᑯᑦ ᐅᕝᕙᓘᓐᓃᑦ ᐃᓚᒃᑯᑦ ᒥᒃᓵᓄᑦ ᐊᑦᑕᕐᓇᖅᑐᒦᑦ ᐃᓱᒪᒃᓴᖅᓯᐅᕈᓐᓇᕐᓂᖅ, ᓴᓇᒥ ᐊᑕᐅᓯᕐᒥ ᓴᙱᓂᖅ, ᐅᕝᕙᓘᓐᓃᑦ ᐅᖃᐅᓯᕐᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᖅ ᑕᑯᒃᓴᐅᒃᑲᓐᓂᕐᐸᑦ, ᓄᓇᓕᓐᓂ ᐊᑦᑐᐃᓂᕐᒧᑦ ᐃᑲᔪᖅᑐᐃᑦ ᓈᓴᐅᑎᖏᓐᓄᑦ ᖃᐅᔨᒋᐊᕐᓗᑎᑦ.
ᐊᐱᖅᑯᑕᐅᒐᔪᒃᑐᑦ
ᑭᓲᑦ 14 ᐋᖅᑭᒋᐊᕈᓐᓇᖅᑐᑦ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᑦ?
2024-mi Lancet Commission-ᑯᑦ ᐅᖃᐅᓯᖏᑦ ᐃᓕᓐᓂᐊᕐᓂᖅ ᐊᒥᓲᙱᓐᓂᖅ, ᑐᓵᓱᓐᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᖅ, LDL ᐅᖅᓱᖅ ᖁᑦᓯᖕᓂᖅ ᐊᐅᒃᑯᑦ, ᐃᓱᒪᒋᔭᐅᙱᓐᓂᖅ, ᓂᐱᐊᒃᑯᑦ ᐋᓐᓂᐊᖃᕐᓂᖅ, ᐊᐅᓚᓂᖅ ᐊᒥᓲᙱᓐᓂᖅ, ᓯᓚᒃᑯᑦ ᐊᐅᒃᓯᒪᓂᖅ, ᐳᔭᖅᑐᓂᖅ, ᐊᐅᒃ ᐱᔪᒃᓴᐅᓂᖅ ᖁᑦᓯᖕᓂᖅ, ᐅᖁᒪᐃᓪᓕᕐᓂᖅ, ᐃᒥᐊᓗᒃᑕᐅᓂᖅ ᐊᒥᓲᓂᖅ, ᐃᓄᒻᒧᑦ ᐊᕕᑦᑐᖅᓯᒪᙱᓐᓂᖅ, ᓯᓚᒐᖃᙱᓐᓂᖅ ᐊᒻᒪ ᐃᔨᓂᒃ ᐋᓐᓂᐊᖃᕐᓂᖅ ᐱᔨᑦᑎᕋᖅᑕᐅᙱᑦᑐᖅ. ᑕᒪᕐᒥᑦᑎᒍᑦ ᐊᑕᖏᖅᑐᑦ ᐃᒪᓐᓇ ᐊᔾᔨᒌᙱᑦᑐᑦ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᓄᑦ ᓄᓇᕐᔪᐊᕐᒥ.
ᓇᓕᐊᖕᓂᑐᐃᓐᓇᖅ ᐃᖅᑲᐃᑦᑐᓕᕆᓂᕐᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ ᐱᔾᔪᑕᐅᔪᖅ ᐱᒻᒪᕆᐅᕙ?
ᓄᓇᕐᔪᐊᕐᒥ ᐃᓄᖕᓄᑦ, Commission-ᑯᑦ ᓇᓗᓇᐃᖅᓯᒪᒻᒪᑦ ᑐᓵᓱᓐᓂᖅ ᐊᔪᕈᓐᓃᕐᓂᖅ ᐊᒻᒪ LDL ᐅᖅᓱᖅ ᖁᑦᓯᖕᓂᖅ ᐊᐅᒃᑯᑦ ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ ᐊᑕᐅᓯᖅ ᐃᒪᓐᓇ 7%-ᒥᒃ ᐊᔾᔨᒌᙱᑦᑐᓂᒃ ᐊᑕᖏᖅᑐᑦ, ᑭᖑᓪᓕᖅᐹᖑᓪᓗᑎᒃ ᐃᓕᓐᓂᐊᕐᓂᖅ ᐊᒥᓲᙱᓐᓂᖅ ᐊᒻᒪ ᐃᓄᒻᒧᑦ ᐊᕕᑦᑐᖅᓯᒪᙱᓐᓂᖅ ᐃᒪᓐᓇ 5%-ᒥᒃ ᐊᑕᐅᓯᖅ. ᐃᓄᒃ ᐊᑕᐅᓯᕐᒧᑦ ᓇᓕᐊᖕᓂᑐᐃᓐᓇᖅ ᐱᒻᒪᕆᐅᕙ ᐋᓐᓂᐊᕈᑎᖓᓄᑦ ᐊᑐᖅᑐᖅ, ᐋᓐᓂᐊᖃᖅᑎ ᐃᑲᔪᖅᑐᐃᔪᓐᓇᕐᒪᑦ ᐱᐅᔪᒥᒃ.
2024-mi ᒪᕐᕉᒃ ᓄᑖᒃ ᐱᔾᔪᑕᐅᔪᒃ ᐃᓚᓯᐅᔪᒃ?
ᐄ. 2024-mi ᐅᓂᒃᑳᖅ ᒪᕐᕉᒃ ᓄᑖᒃ ᐱᔾᔪᑕᐅᔪᒃ ᐃᓚᓯᓚᐅᖅᑐᖅ 12-ᓄᑦ ᐅᖃᐅᓯᔭᐅᓚᐅᖅᑐᓄᑦ 2020-mi: LDL ᐅᖅᓱᖅ ᖁᑦᓯᖕᓂᖅ ᐊᐅᒃᑯᑦ ᐊᖏᕐᕋᓂ ᐃᓅᓯᕐᒥ ᐊᒻᒪ ᐃᔨᓂᒃ ᐋᓐᓂᐊᖃᕐᓂᖅ ᐱᔨᑦᑎᕋᖅᑕᐅᙱᑦᑐᖅ ᐃᓐᓇᐅᓂᕐᒧᑦ ᐃᓅᓯᕐᒥ. Commission-ᑯᑦ ᐊᑕᖏᖅᓯᒪᒻᒪᑦ ᐃᒪᓐᓇ 7%-ᒥᒃ ᐊᒻᒪ 2%-ᒥᒃ ᐊᔾᔨᒌᙱᑦᑐᓂᒃ.
ᐅᑭᐅᖅᑕᖅᑐᖅ ᐋᖅᑭᒋᐊᕈᓐᓇᖅᑐᖅ ᐱᔾᔪᑕᐅᔪᐅᕙ?
ᐋᒃᑲ. ᐅᑭᐅᖅᑕᖅᑐᖅ ᖃᐅᔨᒪᔭᐅᔪᓂᒃ ᐊᖏᓂᖅᓴᐅᔪᖅ ᐱᔾᔪᑕᐅᔪᖅ Alzheimer-ᒧᑦ ᐊᔪᕈᓐᓃᕐᓂᕐᒧᑦ, ᐋᖅᑭᒋᐊᕈᓐᓇᙱᑦᑐᖅ ᑕᐅᑐᒃᑯᑦ. ᑭᖑᓂᐊᒍᑦ ᐱᔾᔪᑕᐅᔪᑦ ᐃᓚᒋᔭᐅᕗᑦ. ᐅᕙᓂ ᒪᒃᐱᖅᑐᒐᕐᒥ 14 ᐱᔾᔪᑕᐅᔪᑦ ᖃᐅᔨᓴᖅᑕᐅᓯᒪᔪᑦ ᐋᖅᑭᒋᐊᕈᓐᓇᖅᑐᑦ ᐃᓱᒪᒋᔭᐅᔪᑦ.
ᓇᑭᙶᕐᓂᖏᑦ
ᑐᕌᕈᑎᖃᖅᐳᒍᑦ ᑲᑐᔾᔨᖃᑎᒌᓄᑦ ᐊᒻᒪ ᖃᐅᔨᓴᕈᑕᐅᓯᒪᔪᓄᑦ ᑕᕝᕙᓂ ᒪᒃᐱᒐᕐᒥ ᑐᙵᕕᒋᔭᐅᔪᓄᑦ. ᐊᑐᓂ ᖃᐅᔨᓴᖅᑕᐅᓚᐅᖅᑐᑦ ᒪᒃᐱᒐᖅ ᓄᑖᙳᕆᐊᖅᑕᐅᑎᓪᓗᒍ.
- Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission · The Lancet
- Nearly half of dementia cases could be prevented or delayed by tackling 14 risk factors · University College London
- Preventing Alzheimer's Disease: What Do We Know? · National Institute on Aging
- What Causes Alzheimer's Disease? · National Institute on Aging
- Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial (SPRINT MIND) · JAMA (via PubMed)